
88PD EFFICACY AND SAFETY OF ERLOTINIB VERSUS CHEMOTHERAPY IN SECOND-LINE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH POOR PROGNOSIS: THE PHASE III TITAN STUDY
Ciuleanu, T., Stelmakh, L., Cicenas, S., Gonzalez, E. EstebanVolume:
71
Langue:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(11)70225-2
Date:
February, 2011
Fichier:
PDF, 74 KB
english, 2011